Dow Drops Cell Culture-Based Production Plan.

Reports on the plan of Dow Chemical Co. to close its biopharmaceutical contract manufacturing facility in Smithfield, Rhode Island. Area of the manufacturing facility; Focus of the biopharmaceutical efforts of the company on new expression systems that clients can use in the production of therapeutic proteins and peptides; Implication of the addition of mammalian cell culture production for the rank of company in chemical industry.